The risks of mesothelioma and lung cancer in relation to relatively lowlevel exposures to different forms of asbestos

Similar documents
ANNEX 2: Assessment of the 7 points agreed by WATCH as meriting attention (cover paper, paragraph 9, bullet points) by Andy Darnton, HSE

Asbestos : Revising the overall summary analysis of cohorts Approach 2

Executive summary. Background

The quantitative risks of mesothelioma and lung cancer in relation to asbestos exposure a comparison of risk models based on asbestos exposed cohorts

Asbestos in Soil and Made Ground

(1) Comparison of studies with different follow-up periods

Asbestos & Cancer: An Update. Suresh H. Moolgavkar, M.D., Ph.D.

Current Usage and Health Significance of the Modern Use of Chrysotile Products: Review of Recently Published Evidence

Scientific Update on Safe Use of Asbestos. Robert P. Nolan, PhD International Environmental Research Foundation New York, New York

Mathematical Modeling of Risk Acceptability Criteria

Influence of Fiber Type, Size, and Number in Human Disease: Conclusions from Fiber Burden Analysis

RR876. Mesothelioma mortality in Great Britain. The revised risk and two-stage clonal expansion models

Mesothelioma mortality in Great Britain Summary 2. Overall scale of disease including trends 3. Region 6. Occupation 7

Asbestos: health effects and risk. Peter Franklin Senior Scientific Officer, EHD Senior Research Fellow, UWA

THE TIMES OF OCCURRENCE OF MESOTHELIOMAS IN RATS FOLLOWING INOCULATION WITH ASBESTOS

Lung cancer and asbestos

Trevor L Ogden BSc. Ph D

PROTOCOL TO ASSESS ASBESTOS-RELATED RISK

Update on Asbestos. Current Issues in Contaminated Land Risk Assessment

Linear functions Increasing Linear Functions. Decreasing Linear Functions

Worldwide mesothelioma mortality trends

NISG Asbestos. Caroline Kirton

Asbestos. Part 1. Overview. What is asbestos? Prepared by: Penny Digby Principal Adviser (Occupational Health) Workplace Health and Safety Queensland

Review of Eliminating occupational cancer in Europe and globally by J. Takala

Executive Summary All invited experts at the meeting agreed that:

Mesothelioma in Australia: Incidence (1982 to 2013) and Mortality (1997 to 2012)

April Asbestos in the university and higher education sector

Exploratory Spatial Data Analysis

Asbestos exposure during Canterbury rebuild unlikely to cause significant health problems for house occupants report finds

The Public Health Significance of Asbestos Exposures from Large Scale Fires

ASBESTOS IN SOIL AND MADE GROUND

ASBESTOS WHAT LIES BENEATH. Your logo here

Asbestos Health Risks. Dr Andrew Pengilley Acting Chief Health Officer

Lessons learned from the Western Australian experience with mesothelioma

- Compensation issues

Mesothelioma Trends as Predictors of the Asbestos- Related Lung Cancer Burden

The Burden of Occupational Lung Cancer Paul A. Demers, PhD

Naturally Occurring Asbestos (NOA) General Overview

Comparison of Mesothelioma Deaths between the Education Sector and Other Occupations.

Your Guide to Asbestos Related Disease Claims

National Strategic Plan for Asbestos Awareness and Management

Health Effects of Asbestos Exposure

PATTERNS OF MORTALITY IN ASBESTOS FACTORY WORKERS IN LONDON*

MESOTHELIOMA MORTALITY IN GREAT BRITAIN: ESTIMATING THE FUTURE BURDEN

Dealing with Data in Excel 2010

ASBESTOS DISEASES. Dr Alastair Robertson

Efficiently Maintaining Commercial Buildings. Asbestos Awareness

Update of the scientific evidence on asbestos and cancer. Kurt Straif, MD MPH PhD. The IARC Monographs

Asbestos - Frequently Asked Questions

Estimation of the Number of Lung Cancer Cases Attributable to Asbestos Exposure

Frequently Asked Questions. What is asbestos? 2. How is asbestos harmful? 2. What illnesses does asbestos cause? 3

Regulatory Risk Assessment

Asbestos is a naturally occurring mineral, with many physical forms, of which the three most important are:

All You Need to Know About Asbestos

Table 2.4. Summary of design and findings from mesothelioma case-control studies

Preparation of a hygienist s legal reports for asbestosinduced. Robin Howie, Robin Howie Associates, Edinburgh

EFFECT OF CHILDREN'S AGE AND LIFE EXPECTATION ON MESOTHELIOMA RISK 1

An Application of the G-formula to Asbestos and Lung Cancer. Stephen R. Cole. Epidemiology, UNC Chapel Hill. Slides:

NHS Barking and Dagenham Briefing on disease linked to Asbestos in Barking & Dagenham

ASBESTOS AWARENESS. Environmental Health And Safety. MAINTENANCE CONTRACTORS

Changing Trends in Mesothelioma Incidence. Hans Weill, M.D. Professor of Medicine Emeritus Tulane University Medical Center

The Carcinogenicity of Chrysotile Asbestos A Review

Animated example of Mr Coscia s trading

Visualizing Data. Contents. 1 Visualizing Data. Anthony Tanbakuchi Department of Mathematics Pima Community College. Introductory Statistics Lectures

UNIVERSITY OF LEICESTER ESTATES & FACILITIES MANAGEMENT DIVISION ASBESTOS MANAGEMENT PLAN

Defending the Rest Basics on Lung Cancer, Other Cancers and Asbestosis: Review of the B-Read and Pulmonary Function Testing

Asbestos and Mesothelioma a briefing document for the Metropolitan Police

Management of Asbestos. Darren Arkins Senior Inspector Occupational Hygiene Unit Chemical Business Services Division

Health effects of occupational exposure to asbestos dust

Asbestos. General information

HEALTH CARE FOR EXPOSURE TO ASBESTOS The SafetyNet Centre for Occupational Health and Safety Research Memorial University

Exposure-risk relationship for aluminium silicate fibres Page - 1 -

Uses and Abuses of Pathology in Asbestos-exposed Populations

ASBESTOS MANAGEMENT POLICY AND GUIDANCE

What is Asbestos? Asbestos was also used in household items, such as: oven gloves ironing board pads simmer mats for stoves fire blankets.


Malignant Mesothelioma

Malignant Mesothelioma

Asbestos risks, safety and its role in lung disease

Malignant Mesothelioma Among Employees of a Connecticut Factory that Manufactured Friction Materials Using Chrysotile Asbestos

Asbestos awareness. University of Brighton 2016

Grade level: secondary Subject: mathematics Time required: 45 to 90 minutes

UKATA. Certificate in Asbestos Awareness. Category A

Findings from Situational Analyses of Asbestos-Related Diseases in the World

Asbestos related health risks

Science-Based Facts Relevant Health Issues For environmental occupational health safe and responsible use

The purpose of this document is to provide guidance on the safe removal and disposal of asbestos and asbestos-containing materials.

Asbestos awareness for Craftsman. Presented by Bob Miller & Andrew Knight

Global Action on Prevention of Asbestos Diseases. Building and Woodworkers International - BWI

Summarizing and Displaying Categorical Data

A. GULF OF MAINE HADDOCK ASSESSMENT SUMMARY FOR 2014

Asbestos Awareness at the University of Toronto

Statistics Chapter 2

Recommendation 3. WATCH is invited to note the issues in the cover paper and annexes and respond to the actions in paragraph 25.

Asbestos Diseases. What Is Asbestos?

The expected burden of mesothelioma mortality in Great Britain from 2002 to 2050

Toxicity of Amphibole Asbestos

Sir William Osler: Listen to the patient; the patient tells you everything.

Transcription:

WATCH/2008/7 Annex 1 The risks of mesothelioma and lung cancer in relation to relatively lowlevel exposures to different forms of asbestos What statements can reliably be made about risk at different exposure levels? Introduction 1. The source data and quantitative risk models for mesothelioma and lung cancer in relation to asbestos exposure have been discussed at three previous WATCH meetings. The main focus of these discussions has been on the quality of the underlying exposure data and the implications of this on the H&D and other risk models. Despite serious limitations, patterns are seen in the data leading to risk models that are notably consistent (though still comprise substantial uncertainty). But the issue of the extent to which these models should be used to make quantitative statements about risk for specific exposure situations particularly where exposures are below the range of exposures for which empirical observations are available has so far not been resolved. 2. As a first step towards making progress on this issue, the purpose of this paper is to elicit your views on the kinds of statements about risk that are justified at different points progressing down the exposure scale. Five separate H&D models exist (mesothelioma in relation to crocidolite, amosite and chrysotile, and lung cancer in relation to amphibole and chrysotile) so in order to keep things manageable, in this paper we will restrict attention to two of these cases as follows: (1) Mesothelioma in relation to amosite (2) Mesothelioma in relation to chrysotile 3. For each case we would like to explore what you think can reliably be said about the risk for three cumulative exposure scenarios. We start with 10 f/ml.yr a relatively high exposure which is still within the range for which empirical observations are available but then move down below this to 1 f/ml.yr and then 0.1 f/ml.yr the latter being most relevant in terms of the exposures we might want to make statements about today. In this paper, all exposures are assumed to be accrued over 5 years starting at age 30, since this was typical of the exposures in the source data. We would like to establish what can reliably be said about risk for this pattern of exposure before any further consideration of exposures accrued over longer periods and starting at different ages. 4. For both cases we ve provided a table which summarises the main features of the risk estimates for the three exposure scenarios with Page 1 of 8

space for you to provide statements about risk. The draft minutes of the June 2008 WATCH meeting state at paragraph 6.18 that a member proposed that WATCH might consider adopting one of three positions with regard to risk estimation: (1) Risks associated with low-level exposure to asbestos cannot be predicted using the existing evidence base (ie no estimates). (2). Reliable absolute predictions about risks associated with low-level exposures to asbestos cannot be made using the HD2000 dose-response model, but it can be used to make predictions about the level of risk of one situation relative to another, in order to prioritise exposure control needs and risk management options (ie relative estimates). (3). The HD2000 linear dose-response relationship is considered to be valid, based on the consideration of the existing evidence base, and can be used to make reliable predictions of risk for low-level exposures (ie absolute estimates). This suggestion might help in your reflections on what you consider can/should be said about the degree of risk involved under the exposure conditions presented in this paper. 5. One important issue in your considerations concerns the question of non-linearity in the H&D models. This is particularly important for the third (ie lowest) exposure scenario where its effect is more pronounced but where models have been extrapolated far below the range of exposures for which there are empirical observations. Your view about the extent to which reliance should be placed on these extrapolated non-linear relationships will inevitably have an impact on what statements you think can be made. Page 2 of 8

Case 1: mesothelioma in relation to amosite exposure Figures 1a and 1b show mesothelioma lifetime risks for cumulative exposure (X) to amosite accrued over 5 years starting at age 30 derived from non-linear H&D best, minimum and maximum models (black lines) and linear models with confidence intervals (red lines). Figure 1a shows risks for exposures up to 100 f/ml.yr and Figure 1b focuses on lower exposures by plotting the data on a logscale. In Figure 1b the three vertical black lines at 10, 1, and 0.1 f/ml.yr represent the three cumulative exposure scenarios we want you to consider. The vertical blue line in the charts represents the bottom end of the range of average cumulative exposures for which we have empirical observations about the risk (5 f/ml.yr): to the left of this we are essentially extrapolating. The horizontal blue line represents a plausible estimate of the background mesothelioma lifetime risk (25 per 100,000) which would apply in countries without industrial asbestos use. This is included to give an additional benchmark when considering what can be said about the risk. At the exposure levels for the three scenarios of interest, the dominant term in the non-linear H&D models is for pleural mesothelioma. For the H&D best model this means the risk is essentially proportional to X 0.75. For the H&D maximum model the relatively much higher risk predicted at lower exposures arises because of more extreme non-linearity: risk is essentially proportional to X 0.6. The minimum model is essentially linear. Page 3 of 8

Figure 1a: lifetime risk of mesothelioma in relation to cumulative exposure to amosite accrued over 5 years from age 30. 12000 Lifetime risk per 100,000 10000 8000 6000 4000 2000 HD "best" HD "min/max" Linear Linear - 95% CI lo/hi 0 0 10 20 30 40 50 60 70 80 90 100 Cumulative exposure (f/ml.yr) Figure 1b: lifetime risk of mesothelioma in relation to cumulative exposure to amosite accrued over 5 years from age 30 (focussing on lower exposures by plotting on log scale) 10000 Scenario 3 0.1 f/ml.yr Lifetime risk per 100,000 1000 100 25 10 HD "best" HD "min/max" Linear Linear - 95% CI lo/hi 16 7 91 70 700 565 Scenario 2 1 f/ml.yr Scenario 1 10 f/ml.yr 1 0.01 0.1 1 5 10 100 Cumulative exposure (f/ml.yr) Page 4 of 8

Table 1: Case 1 mesothelioma in relation to amosite exposure Exposure Summary scenario 10 f/ml.yr Equivalent to constant exposure at a concentration of 2 f/ml (20 times the current control limit) during work time for 5 years. This represents a much higher level of exposure than is likely to be experienced today and is still within the range for which empirical observations are available. Central estimate based on linear model (700 per 100,000) and best estimate non-linear model (565 per 100,000) broadly consistent. Upper end of the range defined by H&D min and max models (165-1400 per 100,000) is about twice the linear estimate. Your statement about risk at this level (see paragraph 4) 1 f/ml.yr Equivalent to constant exposure at a concentration of 0.2 f/ml (twice the current control limit) during work time for 5 years. It is conceivable that some of today s workers could achieve these sorts of exposures if they regularly work with asbestos without taking precautions. However, this exposure is now below the range for which empirical observations are available. Central estimate based on linear model (70 per 100,000) and best estimate non-linear model (91 per 100,000) still broadly consistent but the non-linear model is starting to predict higher risks at this level. Upper end of the range defined by H&D min and max models (15-300 per 100,000) is more than 4 times the linear estimate. 0.1 f/ml.yr Equivalent to constant work-time exposure at a concentration of 0.02 f/ml (1/5 the current control limit) or exposure at the control limit for about 1 working day per week for 5 years This level of exposure could readily be achieved by some workers not taking appropriate precautions today and this scenario is therefore likely to be most relevant to today. However, this exposure is now 1/50 th of the bottom end of the range for which empirical observations are available. Central estimate based on linear model (7 per 100,000) is less than half that of the best estimate non-linear model (16 per 100,000). Upper end of the range defined by H&D min and max models (2-80 per 100,000) is now about 10 times the linear estimate. The lifetime risk likely to be of the same order as the background Page 5 of 8

Case 2: mesothelioma in relation to chrysotile exposure Figures 2a and 2b show mesothelioma lifetime risks for cumulative exposure (X) to chrysotile again accrued over 5 years starting at age 30 derived from non-linear H&D best, minimum and maximum models (black lines) and linear models with confidence intervals (red lines). Figure 2a shows risks for exposures up to 600 f/ml.yr and Figure 2b focuses on lower exposures by plotting the data on a logscale. The same benchmarks (blue lines) and scenarios (black lines) are shown as in Figure 1b. For chrysotile there is no term for peritoneal mesothelioma in the H&D model predicted risk relates only to pleural mesothelioma. For the H&D best model this means the risk is again proportional to X 0.75. For the H&D maximum model the relatively much higher risk predicted at lower exposures arises because of more extreme non-linearity: risk is proportional to X 0.6. The minimum model is linear. Page 6 of 8

Figure 2a: lifetime risk of mesothelioma in relation to cumulative exposure to chrysotile accrued over 5 years from age 30. 700 600 Lifetime risk per 100,000 500 400 300 200 100 0 0 100 200 300 400 500 600 Cumulative exposure (f/ml.yr) Figure 2b: lifetime risk of mesothelioma in relation to cumulative exposure to chrysotile accrued over 5 years from age 30 (focussing on lower exposures by plotting on log scale) 100 25 26 Lifetime risk per 100,000 10 1 0.1 0.8 0.1 5 1 10 Scenario 3 0.1 f/ml.yr Scenario 2 1 f/ml.yr Scenario 1 10 f/ml.yr 0.01 0.01 0.1 1 5 10 100 Cumulative exposure (f/ml.yr) Page 7 of 8

Table 2: Case 2 - mesothelioma in relation to chrysotile exposure Exposure scenario Summary 10 f/ml.yr Equivalent to constant exposure at a concentration of 2 f/ml (20 times the current control limit) during work time for 5 years. This represents a much higher level of exposure than is likely to be experienced today and is still within the range for which empirical observations are available. Central estimate based on linear model (10 per 100,000) is less than half the best non-linear model estimate (26 per 100,000). These risks are of the same order as the background Upper end of the range defined by H&D min and max models (6-70 per 100,000) is 7 times the linear estimate. 1 f/ml.yr Equivalent to constant exposure at a concentration of 0.2 f/ml (twice the current control limit) during work time for 5 years. It is conceivable that some of today s workers could achieve these sorts of exposures if they regularly work with asbestos without taking precautions. However, this exposure is now below the range for which empirical observations are available. Central estimate based on linear model (1 per 100,000) is about 1/5 th the best non-linear model estimate (5 per 100,000). Upper end of the range defined by H&D min and max models (1-18 per 100,000) is 18 times the linear estimate. The estimates are below the background risk level and approaching the region where it is arguable that the risk is insignificant. 0.1 f/ml.yr Equivalent to constant work-time exposure at a concentration of 0.02 f/ml (1/5 the current control limit) or exposure at the control limit for about 1 working day per week for 5 years This level of exposure could readily be achieved by some workers not taking appropriate precautions today and this scenario is therefore the most relevant to today. However, this exposure is now 1/50 th of the bottom end of the range for which empirical observations are available. Central estimate based on linear model (0.1 per 100,000) is about 1/8th the best non-linear model estimate (0.8 per 100,000). Upper end of the range defined by H&D min and max models (0.1-4 per 100,000) is now about 40 times the linear estimate. Estimates are substantially below background. Your statement about risk at this level (see paragraph 4) Page 8 of 8